Crunching the numbers for CNTA... Refresh in a moment for the full analysis.
Centessa Pharmaceuticals plc (CNTA)
Healthcare
mixed
$39.48
Updated: 2026-04-12
50
TradeApes Score
hold
Financial Strength
55
Mixed
Operating Trend
50
Mixed
Valuation
50
Mixed
Capital Allocation
30
Weak
Risk
70
Healthy
Key Findings
+
Net cash position — more cash on hand than total debt
−
Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.